Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y S Cho-Chung

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Cancer Research|November 15, 1990
Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapyY S Cho-Chung
Seminars in Cancer Biology|December 1, 1992
Modulation of adenylate cyclase signallingY S Cho-Chung
Pharmacology & Therapeutics|August 24, 1999
Antisense oligonucleotide inhibition of serine/threonine kinases: an innovative approach to cancer treatmentY S Cho-Chung
Journal of Cyclic Nucleotide Research|January 1, 1980
Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivoY S Cho-Chung
Current Pharmaceutical Design|August 17, 2005
DNA drug design for cancer therapyY S Cho-Chung
Proceedings of the Association of American Physicians|January 1, 1997
Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growthY S Cho-Chung
Antisense & Nucleic Acid Drug Development|January 1, 1996
Protein kinase A-directed antisense restrains cancer growth: sequence-specific inhibition of gene expressionY S Cho-Chung
Pharmacology & Therapeutics|November 1, 1993
The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseasesY S Cho-Chung, T Clair
Current Drug Targets|December 8, 2004
Killing the messenger: antisense DNA and siRNAM Nesterova, Y S Cho-Chung
Nature Medicine|June 1, 1995
A single-injection protein kinase A-directed antisense treatment to inhibit tumour growthM Nesterova, Y S Cho-Chung
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Cancer Research|November 15, 1990
Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapyY S Cho-Chung
Seminars in Cancer Biology|December 1, 1992
Modulation of adenylate cyclase signallingY S Cho-Chung
Pharmacology & Therapeutics|August 24, 1999
Antisense oligonucleotide inhibition of serine/threonine kinases: an innovative approach to cancer treatmentY S Cho-Chung
Journal of Cyclic Nucleotide Research|January 1, 1980
Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivoY S Cho-Chung
Current Pharmaceutical Design|August 17, 2005
DNA drug design for cancer therapyY S Cho-Chung
Proceedings of the Association of American Physicians|January 1, 1997
Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growthY S Cho-Chung
Antisense & Nucleic Acid Drug Development|January 1, 1996
Protein kinase A-directed antisense restrains cancer growth: sequence-specific inhibition of gene expressionY S Cho-Chung
Pharmacology & Therapeutics|November 1, 1993
The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseasesY S Cho-Chung, T Clair
Current Drug Targets|December 8, 2004
Killing the messenger: antisense DNA and siRNAM Nesterova, Y S Cho-Chung
Nature Medicine|June 1, 1995
A single-injection protein kinase A-directed antisense treatment to inhibit tumour growthM Nesterova, Y S Cho-Chung
Pageof 12